Tapentadol is partially metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medication that enrich or repress the activity/expression of a number of of those enzymes, and also with substrates of such enzymes (on account of Competitiveness to the enzyme); some enzyme mediators/substrates involve https://elizabethw565uaf1.wannawiki.com/user